BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results
March 25, 2026 - 01:51
POMPANO BEACH, Fla., March 24, 2026 – BioStem Technologies, Inc., a leader in regenerative medicine, has released its financial results for the fourth quarter and full year ended December 31, 2025. The company, which specializes in perinatal tissue allograft products, reported robust financial metrics for the period.
A key highlight from the report was the generation of $10.1 million in net revenue during the fourth quarter of 2025. The company achieved an exceptionally high gross margin of 97% for that quarter, underscoring the strength of its operational model and product portfolio.
Further solidifying its market position and growth trajectory, BioStem Technologies successfully completed a strategic acquisition. This move is anticipated to enhance the company's capabilities and expand its commercial reach within the regenerative medicine sector. The financial results reflect a period of significant execution and strategic advancement for the company as it continues to focus on developing and commercializing innovative biological solutions for wound care and tissue repair.
MORE NEWS
September 21, 2026 - 02:29
South Korea's Wild Stock Price Swings Are Hurting the Country's ImageSouth Korea`s stock market has earned a reputation as one of the most volatile in the world, and that reputation is starting to carry a cost. Sharp swings in share prices, driven by retail...
September 20, 2026 - 17:10
Credible Transition Plans Drive India's Net Zero FinancingIndia`s net zero transition will require vast investment. Credible corporate transition plans can help investors assess risks and direct capital effectively, write Shantanu Srivastava and Tanya...
September 20, 2026 - 09:51
Nvidia Stock And 2 US AI Infrastructure Plays Tied To Federal Defense SpendingWashington is turning its attention back to artificial intelligence and defense infrastructure. New proposals for an `AI Force` and a dedicated AI tsar point to growing federal interest in chips,...
September 19, 2026 - 19:53
Infosys (INFY) Lands a Brake Maker as Growth Stays in Low GearInfosys announced on August 18 a long-term agreement to handle the enterprise software operations for Knorr-Bremse AG, a German manufacturer of braking systems used in rail and commercial vehicles....